A detailed history of Bvf Inc transactions in Ac Immune Sa stock. As of the latest transaction made, Bvf Inc holds 19,522,436 shares of ACIU stock, worth $69.3 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
19,522,436
Previous 18,834,936 3.65%
Holding current value
$69.3 Million
Previous $75.2 Million 1.81%
% of portfolio
2.35%
Previous 2.3%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.99 - $4.2 $2.06 Million - $2.89 Million
687,500 Added 3.65%
19,522,436 $73.8 Million
Q2 2024

Aug 14, 2024

BUY
$2.29 - $4.87 $9.76 Million - $20.8 Million
4,263,700 Added 29.26%
18,834,936 $75.2 Million
Q4 2023

Feb 14, 2024

BUY
$2.46 - $5.0 $17.6 Million - $35.7 Million
7,142,857 Added 96.16%
14,571,236 $72.9 Million
Q1 2022

May 16, 2022

BUY
$3.5 - $5.16 $1.28 Million - $1.89 Million
366,000 Added 5.18%
7,428,379 $29.7 Million
Q4 2021

Feb 14, 2022

BUY
$4.83 - $7.56 $614,376 - $961,632
127,200 Added 1.83%
7,062,379 $35 Million
Q3 2021

Nov 15, 2021

SELL
$6.2 - $8.34 $9.98 Million - $13.4 Million
-1,610,000 Reduced 18.84%
6,935,179 $46.5 Million
Q2 2021

Aug 16, 2021

BUY
$6.04 - $8.37 $6.29 Million - $8.71 Million
1,040,600 Added 13.87%
8,545,179 $67.8 Million
Q1 2021

May 17, 2021

SELL
$5.32 - $8.96 $12.3 Million - $20.7 Million
-2,312,079 Reduced 23.55%
7,504,579 $57.1 Million
Q4 2020

Feb 12, 2021

SELL
$4.47 - $5.58 $9,387 - $11,718
-2,100 Reduced 0.02%
9,816,658 $50.8 Million
Q3 2020

Nov 13, 2020

SELL
$4.78 - $9.06 $7.17 Million - $13.6 Million
-1,500,000 Reduced 13.25%
9,818,758 $47.9 Million
Q2 2020

Aug 14, 2020

SELL
$6.57 - $8.3 $156,017 - $197,100
-23,747 Reduced 0.21%
11,318,758 $76.2 Million
Q4 2019

Feb 14, 2020

BUY
$4.56 - $8.78 $203,348 - $391,535
44,594 Added 0.39%
11,342,505 $96.6 Million
Q3 2019

Nov 14, 2019

BUY
$4.8 - $5.89 $7.1 Million - $8.71 Million
1,478,477 Added 15.06%
11,297,911 $55.9 Million
Q2 2019

Aug 14, 2019

BUY
$4.72 - $5.88 $11.2 Million - $13.9 Million
2,363,900 Added 31.71%
9,819,434 $54.5 Million
Q1 2019

May 15, 2019

BUY
$3.65 - $11.68 $19.1 Million - $61 Million
5,225,507 Added 234.32%
7,455,534 $37.7 Million
Q4 2018

Feb 14, 2019

BUY
$7.35 - $11.7 $1.56 Million - $2.49 Million
212,527 Added 10.53%
2,230,027 $21.1 Million
Q3 2018

Nov 14, 2018

BUY
$7.88 - $16.45 $15.9 Million - $33.2 Million
2,017,500 New
2,017,500 $16.1 Million

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $296M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.